Essential fatty acids in serum and cerebrospinal fluid of patients during multiple sclerosis
Neu, I.
Der Nervenarzt 52(2): 100-107
1981
ISSN/ISBN: 0028-2804 PMID: 7219616 Document Number: 180606
Document emailed within 1 workday
Related Documents
Niezgoda, A.; Losy, J. 2000: The effect of cladribine treatment on beta-2 microglobin in the cerebrospinal fluid and serum of patients with multiple sclerosis Neurologia i Neurochirurgia Polska 34(2): 281-287Zamboni, P.; Menegatti, E.; Weinstock-Guttman, B.; Schirda, C.; Cox, J.L.; Malagoni, A.M.; Hojanacki, D.; Kennedy, C.; Carl, E.; Dwyer, M.G.; Bergsland, N.; Galeotti, R.; Hussein, S.; Bartolomei, I.; Salvi, F.; Zivadinov, R. 2009: The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics Functional Neurology 24(3): 133-138
Cendrowski, W.; Niedzielska, K. 1974: Multiple sclerosis: etiologic and diagnostic significance of measles virus antibodies in the cerebrospinal fluid and serum Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 114(2): 215-228
Tate, J.; Campbell, B. 1988: Must CSF oligoclonal bands be unique to cerebrospinal fluid and absent from serum to support the diagnosis of multiple sclerosis? Clinical Chemistry 34(7): 1521-1522
Kaleemullah, A.J.; O'Kell, R.T. 1976: Evaluation of multiple sclerosis patients by cerebrospinal fluid Missouri Medicine 73(9): 520-522
Tsai, S.J.; Chiu, H.C.; Su, C.L.; Wang, C.R. 1990: Cerebrospinal fluid study in Chinese patients with multiple sclerosis Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 23(2): 189-196
Seres, E.; Bencsik, K.; Rajda, C.; Vécsei, L. 1998: Diagnostic studies of cerebrospinal fluid in patients with multiple sclerosis Orvosi Hetilap 139(32): 1905-1908
Duquette, P.; Charest, L. 1986: Cerebrospinal fluid findings in healthy siblings of multiple sclerosis patients Neurology 36(5): 727-729
Lubetzki, C.; Lombrail, P.; Hauw, J.J.; Baumann, N.; Zalc, B. 1987: Binding of immunoglobulins of the cerebrospinal fluid of multiple sclerosis patients to oligodendrocytes in culture Pathologie-Biologie 35(3): 314-318
Tavolato, B. 1972: Immunoglobulin G in cerebrospinal fluid of patients with multiple sclerosis. Study with immunosuppression. Preliminary report Acta Neurologica 27(2): 121-122
Rodriguez, M.; Wynn, D.R.; Kimlinger, T.K.; Katzmann, J.A. 1990: Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls Neurology 40(5): 855-857
Tournier-Lasserve, E.; Lyoncaen, O.; Roullet, E.; Bach, M.A. 1987: IL-2 receptor and HLA class Ii antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases Clinical and Experimental Immunology 67(3): 581-586
Stelmasiak, Z.; Bartosik-Psujek, H.; Belniak-Legieć, E.; Mitosek-Szewczyk, K. 2000: The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS) Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 55: 221-225
Totolian, N.A.; Luchakova, O.S. 1996: Antibodies to brain galactocerebrosides in the serum and cerebrospinal fluid of patients with disseminated sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 96(4): 75-77
Wender, M.; Michałowska, G. 1986: IgG synthesis in the cerebrospinal fluid in patients with the chronic progressive phase of multiple sclerosis treated with cyclophosphamide and ACTH Neurologia i Neurochirurgia Polska 20(6): 536-541
Massaro, A.R.; De Pascalis, D.; Carnevale, A.; Carbone, G. 2009: The neural cell adhesion molecule (NCAM) present in the cerebrospinal fluid of multiple sclerosis patients is unsialylated European Review for Medical and Pharmacological Sciences 13(5): 397-399
Niebrój-Dobosz, I.; Domitrz, I.; Mickielewicz, A. 1999: Cytotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients against acetylcholinesterase Folia Neuropathologica 37(2): 107-112
Tabira, T.; Webster, H.F.; Wray, S.H. 1975: Demyelinating activity of cerebrospinal fluid from multiple sclerosis patients tested in a new model system, the optic nerves of xenopus tadpoles Transactions of the American Neurological Association 100: 103-106
Roelcke, U.; Heil, J. 1993: Fatty acids as markers of the blood-cerebrospinal fluid barrier function in man Functional Neurology 8(3): 189-192
Garcia, J.; Ghisolfi, J.; Lapalu-Traon, C.; Periquet, B.; Olives, J.P.; Boyer, M.J.; Thouvenot, J.P. 1986: Screening of essential fatty acid deficiency in children. Respective value of the assay of fatty acids in total lipids and lipid fractions of the serum Annales de Biologie Clinique 44(4): 380-383